CAG beat Q2 EPS estimates, but sales fell 6.8% and organic net sales dropped 3% as volumes declined amid a tough consumer backdrop.
Today, retail giant Target Corporation (NYSE: TGT) reported its third-quarter fiscal 2025 earnings. Unfortunately, for the company and its investors, the results were a continuation of what Target has ...
Merck MRK is facing persistent challenges for its second-largest product, Gardasil, which is a vaccine for the prevention of certain cancers caused by human papillomavirus. Though the vaccine’s sales ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback